These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25910526)

  • 1. Reply: To PMID 25465934.
    Sassone B; Bertini M
    Am J Cardiol; 2015 Jun; 115(12):1781-2. PubMed ID: 25910526
    [No Abstract]   [Full Text] [Related]  

  • 2. A new paradigm in cardiac resynchronization therapy?
    Polasek R; Wichterle D; Kautzner J
    Am J Cardiol; 2015 Jun; 115(12):1781. PubMed ID: 25907502
    [No Abstract]   [Full Text] [Related]  

  • 3. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology.
    Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W
    Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of left ventricular reverse remodeling.
    Aksu U; Kalkan K
    Int J Cardiol; 2016 Nov; 222():1055. PubMed ID: 27138699
    [No Abstract]   [Full Text] [Related]  

  • 5. Left ventricular versus biventricular for cardiac resynchronization therapy: comparable but not equal.
    Saxon LA
    Circulation; 2011 Dec; 124(25):2803-4. PubMed ID: 22184041
    [No Abstract]   [Full Text] [Related]  

  • 6. New insights into ventricular interactions during cardiac resynchronization.
    Daubert C; Behaghel A; Martins RP
    J Am Coll Cardiol; 2013 Dec; 62(25):2404-2405. PubMed ID: 24013053
    [No Abstract]   [Full Text] [Related]  

  • 7. Predicting Clinical and Echocardiographic Response After Cardiac Resynchronization Therapy With a Score Combining Clinical, Electrocardiographic, and Echocardiographic Parameters.
    Bernard A; Menet A; Marechaux S; Fournet M; Schnell F; Guyomar Y; Leclercq C; Mabo P; Fauchier L; Donal E
    Am J Cardiol; 2017 Jun; 119(11):1797-1802. PubMed ID: 28400028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter by van Gelder and Bracke regarding article, "Left ventricular versus simultaneous biventricular pacing in patients with heart failure and a QRS complex >120 milliseconds".
    van Gelder BM; Bracke FA
    Circulation; 2012 Oct; 126(15):e238; author reply e239. PubMed ID: 23044613
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to the Editor--LA function is not the only key for best selection of candidates for cardiac resynchronization therapy, but LA strain provides valuable information!
    Donal E; Feneon D; Galli E
    Heart Rhythm; 2015 Dec; 12(12):e141-2. PubMed ID: 26291763
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiac Resynchronization Therapy for Mild Heart Failure: Compelling Evidence of Long-Term Benefits.
    Estes NA
    JACC Heart Fail; 2015 Sep; 3(9):701-2. PubMed ID: 26277766
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of QRS complex duration and morphology on left ventricular reverse remodelling and left ventricular function improvement after cardiac resynchronization therapy.
    van der Bijl P; Khidir M; Leung M; Mertens B; Ajmone Marsan N; Delgado V; Bax JJ
    Eur J Heart Fail; 2017 Sep; 19(9):1145-1151. PubMed ID: 28176418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of QRS duration to response to cardiac resynchronization therapy.
    Sassone B; Gambetti S; Bertini M; Beltrami M; Mascioli G; Bressan S; Fucà G; Pacchioni F; Pedaci M; Michelotti F; Bacchi Reggiani ML; Padeletti L
    Am J Cardiol; 2015 Jan; 115(2):214-9. PubMed ID: 25465934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.
    Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR;
    Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter by Dai et al regarding article, "cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trial".
    Dai H; Guang X; Xiao Z
    Circulation; 2013 Oct; 128(14):e217. PubMed ID: 24081959
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter by Banker et al regarding article, "cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trial".
    Banker J; Rosenheck S; Gotsman I
    Circulation; 2013 Oct; 128(14):e216. PubMed ID: 24081958
    [No Abstract]   [Full Text] [Related]  

  • 16. The clinical benefit of cardiac resynchronization therapy for narrow QRS compared to broad QRS complex patients.
    Yap LB; Qadir F; Nguyen ST; Ma SK; Koh KW; Muhammad Z; Arshad AH; Ali Z; Daud A; Tay GS; Sahat NA; Said AA; Tamin SS; Hussin A; Kaur S; Omar R
    Int J Cardiol; 2015 Mar; 183():178-9. PubMed ID: 25666128
    [No Abstract]   [Full Text] [Related]  

  • 17. Narrow QRS is not the right substrate for cardiac resynchronization therapy.
    Moss AJ
    Circulation; 2013 Mar; 127(10):1093-4. PubMed ID: 23388214
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiac Simulation to Personalize Cardiac Resynchronization Therapy.
    Delgado V; Bax JJ
    Circ Cardiovasc Imaging; 2015 Sep; 8(9):e003985. PubMed ID: 26338879
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute effects of withdrawal of cardiac resynchronization therapy on left and right ventricular function, dyssynchrony, and contractile function in patients with New York Heart Association functional class I/II heart failure: MADIT-CRT.
    Knappe D; Pouleur AC; Shah AM; Bourgoun M; Brown MW; Foster E; Pfeffer MA; Moss AJ; Solomon SD;
    J Card Fail; 2013 Mar; 19(3):149-55. PubMed ID: 23482074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin is associated with reverse remodeling after cardiac resynchronization therapy in patients with heart failure and ventricular dyssynchrony.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Piccolo R; Galasso G; Reiter RJ
    Int J Cardiol; 2016 Oct; 221():359-63. PubMed ID: 27404706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.